| SCHEDULE OF FINANCIAL INSTRUMENTS |
SCHEDULE OF FINANCIAL INSTRUMENTS
| | |
As
of
January 4, 2023 | |
| | |
| |
| Derivative
liabilities – Fair value of the Warrants | |
$ | 3,858,521 | |
| Derivative
liabilities – Embedded conversion feature | |
| 1,247,500 | |
| Convertible
Notes | |
| 9,893,979 | |
| | |
$ | 15,000,000 | |
|
| SCHEDULE OF CONVERTIBLE NOTES OBLIGATION |
The
Company’s Convertible Notes’ obligations were as the following for the three and nine months ended December 31, 2025 and
2024:
SCHEDULE OF CONVERTIBLE NOTES OBLIGATION
| | |
Three
months ended | | |
Nine
months ended | |
| | |
December
31, | | |
December
31, | |
| | |
2025 | | |
2024 | | |
2025 | | |
2024 | |
| Carrying
value – beginning balance | |
$ | - | | |
$ | 3,214,514 | | |
$ | 2,900,160 | | |
$ | 2,684,697 | |
| Converted
to ordinary shares | |
| - | | |
| - | | |
| (3,054,240 | ) | |
| (82,642 | ) |
| Redemption | |
| - | | |
| (544,706 | ) | |
| (334,534 | ) | |
| (544,706 | ) |
| Amortization
of debt discount | |
| - | | |
| 74,113 | | |
| 418,510 | | |
| 756,761 | |
| Deferred
debt discount and cost of issuance | |
| - | | |
| 15,633 | | |
| - | | |
| (250,136 | ) |
| Interest
charge | |
| - | | |
| 37,589 | | |
| 70,104 | | |
| 233,169 | |
| Carrying
value – ending balance | |
$ | Nil | | |
$ | 2,797,143 | | |
$ | Nil | | |
$ | 2,797,143 | |
|
| SCHEDULE OF DERIVATIVE LIABILITIES |
The
Company’s derivative liabilities were as the following for the three and nine months ended December 31, 2025 and 2024:
SCHEDULE OF DERIVATIVE LIABILITIES
| | |
2025 | | |
2024 | | |
2025 | | |
2024 | |
| | |
Three
months ended | | |
Nine
months ended | |
| | |
December
31, | | |
December
31, | |
| | |
2025 | | |
2024 | | |
2025 | | |
2024 | |
| Derivative
liabilities –Warrants | |
$ | | | |
$ | | | |
$ | | | |
$ | | |
| Beginning
balance | |
| 1,191,178 | | |
| 301,989 | | |
| 989,852 | | |
| 251,657 | |
| Marked
to the market | |
| 4,141,237 | | |
| 352,320 | | |
| 4,342,563 | | |
| 402,652 | |
| Ending
fair value | |
| 5,332,415 | | |
| 654,309 | | |
| 5,332,415 | | |
| 654,309 | |
| | |
| | | |
| | | |
| | | |
| | |
| Derivative
liabilities – Embedded conversion feature | |
| | | |
| | | |
| | | |
| | |
| Beginning
balance | |
| - | | |
| 645,958 | | |
| 1,782,498 | | |
| 36,298 | |
| Converted
to shares of Common Stock | |
| - | | |
| - | | |
| (1,589,352 | ) | |
| (1,330 | ) |
| Remeasurement
on change of convertible price | |
| - | | |
| (15,633 | ) | |
| 17,625 | | |
| 248,292 | |
| Redemption | |
| - | | |
| (103,786 | ) | |
| (8,979 | ) | |
| (103,786 | ) |
| Marked
to the market | |
| | | |
| 297,575 | | |
| (201,792 | ) | |
| 644,641 | |
| Ending
fair value | |
| Nil | | |
| 824,115 | | |
| Nil | | |
| 824,115 | |
| | |
| | | |
| | | |
| | | |
| | |
| Total
Derivative fair value at end of period | |
$ | 5,332,415 | | |
$ | 1,478,424 | | |
$ | 5,332,415 | | |
$ | 1,478,424 | |
|